InnoVentiv Europe SRL
InnoVentiv Europe reported total assets of 562,964 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Sep 2026).
The score of InnoVentiv Europe shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +37 % Total assets +92 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
InnoVentiv Europe's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Sep 2026
- Year ended 31 Dec 2024filed on 29 Sep 2025
- Year ended 31 Dec 2023filed on 31 Aug 2024
- Year ended 31 Dec 2022filed on 27 Jul 2023
InnoVentiv Europe's financial analysis
- Solvency15.2%sector median: 32.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of InnoVentiv Europe
InnoVentiv Europe's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0783.845.320
- VAT number
- BE0783845320
- Peppol
- Registered · 0208:0783845320 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 25 Mar 2022
- Registered office
- 1082 Berchem-Sainte-Agathe
- Latest accounts
- 2025 · filed on 29 Sep 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
InnoVentiv Europe (SRL) has been based in Berchem-Sainte-Agathe since 2022, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net loss of 107 € and equity of 85,557 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to InnoVentiv Europe
Companies in the same business, of comparable size and area, outside its group.
- Medi-TEK Rental and leasing of other personal and household goods Jette · balance sheet 120,294 €
- Business Executive Service Company Rental and leasing of other personal and household goods Genappe · balance sheet 74,585 €
- Meditron Wholesale of pharmaceutical and medical goods Sint-Gillis-Waas · balance sheet 488,085 €
- Laboratoire Cardio Contact Benelux Rental and leasing of other personal and household goods Uccle · balance sheet 955,974 €
- Rent Medic Activities of agents involved in non-specialised wholesale La Hulpe · balance sheet 852,295 €
- Infimed Benelux Rental and leasing of other personal and household goods Tournai · balance sheet 950,289 €
- Lifehouse Wholesale of pharmaceutical and medical goods Kortrijk · balance sheet 196,011 €
- Omedis Rental and leasing of other personal and household goods Wavre · balance sheet 456,656 €
Frequently asked questions about InnoVentiv Europe
What is the revenue of InnoVentiv Europe?
InnoVentiv Europe files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of InnoVentiv Europe?
In Belgium, the VAT number is the company number prefixed with BE: BE0783845320 for InnoVentiv Europe, if the company is VAT-registered. Its company number (CBE) is 0783.845.320.
Where is the registered office of InnoVentiv Europe?
According to the CBE register, the registered office of InnoVentiv Europe is in 1082 Berchem-Sainte-Agathe.
What is the equity of InnoVentiv Europe?
At the close of the 2025 financial year, the equity of InnoVentiv Europe amounts to 85,557 €, a solvency of 15.2% of total assets.
Who manages InnoVentiv Europe?
The register lists 1 active mandates at InnoVentiv Europe. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of InnoVentiv Europe
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →